Metformin's effects beyond ischemia: Evaluating cardioprotection in nonischemic myocardium in a large animal model of coronary and metabolic disease.

J Thorac Cardiovasc Surg · 2026 · PMC13264963 · PMID 41093005

Europe PMC DOI

hedged sentence

0.0683

closest p · 1.4× alpha

0.0683

boldest claim

The sentences

did not reach statistical significanceP = .0683so close (0.05 < p ≤ 0.1)

End-systolic volume (Ves) was also lower in the MET group, although this difference did not reach statistical significance ( P = .0683).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.